Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
CNOOC
00883
5
YANCHANG PETRO
00346
CN Stock MarketDetailed Quotes
Jiangsu Canopus Wisdom Medical Technology (301290)
- 27.61
- -0.05-0.18%
Market Closed Apr 17 15:00 CST
2.77BMarket Cap-129.62P/E (TTM)
27.80High27.40Low10.32KlotVolume27.80Open27.66Prev Close28.48MTurnover1.51%Turnover Ratio28.38P/E (Static)100.17MShares31.1852wk High1.30P/B1.88BFloat Cap21.3152wk Low33.19Limit Up68.16MShs Float57.32Historical High22.13Limit Down1.45%Range %15.42Historical Low0.60Dividend TTM27.61Avg Price5.18KlotAsk2.17%Div Yield TTM100Lot Size4.76KlotBid
Jiangsu Canopus Wisdom Medical Technology (301290) Income Statement
All
YOY
| (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | -10.21%283.74M | -14.17%183.29M | -14.84%78.19M | 0.40%435.46M | 1.57%316.02M | 5.82%213.55M | 9.27%91.81M | -1.89%433.73M | -2.08%311.12M | -4.79%201.8M |
| Operating revenue | -10.21%283.74M | -14.17%183.29M | -14.84%78.19M | 0.40%435.46M | 1.57%316.02M | 5.82%213.55M | 9.27%91.81M | -1.89%433.73M | -2.08%311.12M | -4.79%201.8M |
| Other operating revenue | ---- | 32.14%3.02M | ---- | 54.50%4.99M | ---- | 98.75%2.28M | ---- | 136.31%3.23M | ---- | 56.34%1.15M |
| Total operating cost | -7.67%245.52M | -8.38%163.13M | -7.44%72.37M | 1.98%358.93M | 6.20%265.92M | 9.45%178.06M | 12.15%78.19M | 6.74%351.95M | 5.82%250.38M | 5.98%162.69M |
| Operating cost | -8.91%147.47M | -12.52%97.57M | -10.47%43.47M | -1.71%220.49M | 0.07%161.89M | 7.21%111.54M | 12.91%48.55M | 6.32%224.33M | 13.07%161.78M | 11.38%104.04M |
| Operating tax surcharges | 11.11%4.04M | 11.61%2.5M | 9.05%1.06M | 26.42%5.18M | 31.21%3.64M | 24.23%2.24M | 23.30%972.21K | -6.65%4.1M | -15.87%2.77M | -16.21%1.8M |
| Operating expense | -5.07%33.79M | -1.38%22.31M | -15.83%8.19M | 12.61%47.58M | 22.98%35.6M | 14.48%22.62M | 7.16%9.73M | 10.32%42.25M | -0.95%28.95M | 7.32%19.76M |
| Administration expense | -8.34%46.61M | -6.92%32.25M | -3.87%15.24M | 1.13%65.37M | 11.82%50.85M | 15.51%34.65M | 26.24%15.85M | 17.84%64.64M | 5.92%45.48M | 6.00%30M |
| Financial expense | 118.10%499.62K | 103.01%81.5K | 114.06%242.47K | 79.72%-2.12M | 68.72%-2.76M | 55.80%-2.71M | 12.98%-1.72M | -248.42%-10.47M | -2,698.03%-8.82M | -2,740.40%-6.13M |
| -Interest expense (Financial expense) | 337.42%862.32K | 365.36%518.2K | 728.92%176.91K | 436.61%338.53K | 244.93%197.14K | 30.61%111.36K | 29.86%21.34K | -52.90%63.09K | -46.23%57.15K | 26.56%85.26K |
| -Interest Income (Financial expense) | 74.90%-809.92K | 73.65%-777.55K | 93.46%-115.4K | 74.57%-2.7M | 64.08%-3.23M | 52.94%-2.95M | 8.13%-1.76M | -261.98%-10.62M | -5,962.38%-8.98M | -5,876.64%-6.27M |
| Research and development | -21.50%13.11M | -13.41%8.42M | -13.22%4.17M | -17.26%22.43M | -17.49%16.7M | -26.49%9.72M | -23.44%4.8M | 11.99%27.11M | 10.00%20.24M | 15.43%13.23M |
| Credit Impairment Loss | 190.80%1.28M | 411.41%1.29M | 106.38%1.02M | -2,082.21%-246.81K | -651.02%-1.41M | -140.06%-415.46K | -52.78%493.52K | 99.58%-11.31K | 122.18%255.57K | 187.92%1.04M |
| Asset Impairment Loss | -31,463.32%-103.63M | -85.84%19.65K | -186.74%-29.65K | 45.64%-480.31K | 270.35%330.43K | 234.92%138.75K | -48.05%34.18K | -407.91%-883.61K | -163.44%-193.98K | -11,549.67%-102.84K |
| Other net revenue | -382.95%-80.75M | -25.07%16.32M | -16.97%8.49M | 11.03%39.11M | 8.24%28.54M | -2.15%21.78M | 35.16%10.22M | 481.99%35.22M | 246.04%26.37M | 1,598.42%22.26M |
| Fair value change income | 111.03%807.28K | 159.68%2.66M | 102.15%107.68K | -151.13%-7M | -171.36%-7.32M | -159.80%-4.46M | -217.96%-5.01M | 2,641.90%13.69M | 1,308.72%10.25M | 1,229.05%7.46M |
| Invest income | -31.95%18.89M | -38.93%11.14M | -46.31%6.49M | 551.53%36.7M | 843.49%27.77M | 1,467.75%18.25M | 6,748.64%12.08M | 139.82%5.63M | 51.29%2.94M | -2.47%1.16M |
| Asset deal income | 44.69%-18.73K | 64.35%-12.07K | 99.13%-356.13 | 76.55%-83.68K | -439.44%-33.86K | -638.92%-33.86K | -749.17%-40.78K | -0.16%-356.87K | 104.97%9.97K | 103.13%6.28K |
| Other revenue | -79.11%1.92M | -85.44%1.21M | -66.04%904.71K | -40.39%10.22M | -29.76%9.2M | -34.60%8.3M | 31.84%2.66M | 187.67%17.15M | 118.57%13.1M | 1,255.04%12.69M |
| Operating profit | -154.09%-42.53M | -36.31%36.48M | -40.03%14.3M | -1.17%115.64M | -9.71%78.64M | -6.68%57.27M | 9.07%23.85M | -1.20%117.01M | -1.83%87.1M | 2.70%61.37M |
| Add:Non operating Income | 10.98%92.27K | 41.01%76.26K | -24.04%18.85K | -44.20%177.25K | -73.44%83.15K | -49.28%54.08K | -79.65%24.81K | -79.31%317.65K | -68.73%313.09K | -88.04%106.63K |
| Less:Non operating expense | -8.52%649.7K | -5.63%646.79K | -83.12%17.63K | 190.67%756.94K | 4,681.68%710.21K | 6,146.94%685.4K | 34,285.78%104.46K | 80.25%260.41K | -89.07%14.85K | -84.68%10.97K |
| Total profit | -155.24%-43.09M | -36.61%35.91M | -39.82%14.3M | -1.71%115.06M | -10.74%78.01M | -7.85%56.64M | 8.11%23.77M | -2.30%117.06M | -2.44%87.4M | 1.47%61.47M |
| Less:Income tax cost | -17.00%10.43M | -31.90%6.25M | -37.03%2.63M | 5.77%18.17M | -8.91%12.57M | -4.61%9.18M | 22.04%4.17M | 6.71%17.18M | 14.31%13.8M | 15.98%9.63M |
| Net profit | -181.78%-53.52M | -37.51%29.65M | -40.42%11.67M | -2.99%96.89M | -11.08%65.45M | -8.45%47.46M | 5.54%19.59M | -3.70%99.88M | -5.05%73.6M | -0.84%51.84M |
| Net profit from continuing operation | -181.78%-53.52M | -37.51%29.65M | -40.42%11.67M | -2.99%96.89M | -11.08%65.45M | -8.45%47.46M | 5.54%19.59M | -3.70%99.88M | -5.05%73.6M | -0.84%51.84M |
| Less:Minority Profit | -142.77%-320.15K | -188.15%-638.52K | -31.17%-390.38K | -120.06%-533.57K | -106.02%-131.88K | -112.29%-221.59K | -151.88%-297.61K | 119.76%2.66M | 301.75%2.19M | 3,901.11%1.8M |
| Net profit of parent company owners | -181.13%-53.2M | -36.47%30.29M | -39.35%12.06M | 0.21%97.42M | -8.17%65.58M | -4.71%47.68M | 10.56%19.89M | -5.15%97.22M | -7.23%71.41M | -4.37%50.03M |
| Earning per share | ||||||||||
| Basic earning per share | -180.30%-0.53 | -37.50%0.3 | -40.00%0.12 | 1.03%0.98 | -7.04%0.66 | -4.00%0.48 | 11.11%0.2 | -27.07%0.97 | -30.39%0.71 | -28.57%0.5 |
| Diluted earning per share | -180.30%-0.53 | -37.50%0.3 | -40.00%0.12 | 1.03%0.98 | -7.04%0.66 | -4.00%0.48 | 11.11%0.2 | -27.07%0.97 | -30.39%0.71 | -28.57%0.5 |
| Other composite income | ||||||||||
| Total composite income | -181.78%-53.52M | -37.51%29.65M | -40.42%11.67M | -2.99%96.89M | -11.08%65.45M | -8.45%47.46M | 5.54%19.59M | -3.70%99.88M | -5.05%73.6M | -0.84%51.84M |
| Total composite income of parent company owners | -181.13%-53.2M | -36.47%30.29M | -39.35%12.06M | 0.21%97.42M | -8.17%65.58M | -4.71%47.68M | 10.56%19.89M | -5.15%97.22M | -7.23%71.41M | -4.37%50.03M |
| Total composite income of minority owners | -142.77%-320.15K | -188.15%-638.52K | -31.17%-390.38K | -120.06%-533.57K | -106.02%-131.88K | -112.29%-221.59K | -151.88%-297.61K | 119.76%2.66M | 301.75%2.19M | 3,901.11%1.8M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Market Insights
Hot Topics Hot Topics
Middle East conflict spreads to the stock market! How should investors respond?
Lebanon and Israel will implement a 10-day ceasefire! On the 16th, US President Trump stated that the next round of talks between the US and
牛牛課堂
Mar 4 17:09
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
牛牛課堂
Mar 18 18:18
Hormuz, Term Structure and USO: Navigating the Energy Storm